Biomarkers of lipopolysaccharide-associated phenotypes in gout patients
Journal: Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice
Year: 2025

Gout is a chronic metabolic disease that occupies a significant place among chronic diseases worldwide. In 2020, 55.8 million people worldwide suffered from gout, corresponding to 0.7% of all mankind, and the prevalence continues to increase annually. Given the increasing incidence of gout, more personalized approaches to the treatment of patients with gout need to be developed. This study aimed to identify various subgroups (phenotypes) of gout patients and describe their characteristics based